{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:10:47Z","timestamp":1782288647031,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1053\/j.ajkd.2003.12.003","type":"journal-article","created":{"date-parts":[[2004,2,23]],"date-time":"2004-02-23T13:28:34Z","timestamp":1077542914000},"page":"558-565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy"],"prefix":"10.1053","volume":"43","author":[{"given":"Kevin J","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Olgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack W","family":"Coburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio M","family":"Coen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Langman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut H","family":"Malluche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaul G","family":"Massry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Mehls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro B","family":"Salusky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslaw T","family":"Smogorzewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo M","family":"Slatopolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2003.12.003_BIB1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2003.12.004","article-title":"Osteoporosis in chronic kidney disease","volume":"43","author":"Cunningham","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1525-139X.2003.160631.x","article-title":"Bone biopsy","volume":"16","author":"Trueba","year":"2003","journal-title":"Semin Dial"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.ndt.a027404","article-title":"Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure","volume":"11","author":"Coen","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041552-200307000-00007","article-title":"Renal bone disease","volume":"12","author":"Parfitt","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1073-4449(12)80068-9","article-title":"Aplastic bone","volume":"2","author":"Sherrard","year":"1995","journal-title":"Adv Ren Replace Ther"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2003.12.003_BIB6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/11.supp3.29","article-title":"The aplastic form of renal osteodystrophy","volume":"11","author":"Sherrard","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jbmr.5650100121","article-title":"Risk factors for renal osteodystrophy","volume":"10","author":"Pei","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000057611","article-title":"Renal osteodystrophy in predialysis and hemodialysis patients","volume":"91","author":"Coen","year":"2002","journal-title":"Nephron"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5414\/CNP59313","article-title":"Parathyroid hormone assays\u2014Evolution and revolutions in the care of dialysis patients","volume":"59","author":"Malluche","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0272-6386(95)90453-0","article-title":"Relationship between intact 1\u201384 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity","volume":"26","author":"Wang","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00041552-200109000-00004","article-title":"The evolution of assays for parathyroid hormone","volume":"10","author":"Martin","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB12","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0272-6386(03)00296-8","article-title":"PTH 1\u201384, PTH fragments and bone turnover","volume":"41","author":"Malluche","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/ajkd.2002.34519","article-title":"PTH 1\u201384 and PTH \u201c7\u201384\u201d in the noninvasive diagnosis of renal bone disease","volume":"40","author":"Coen","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1523-1755.2003.00700.x","article-title":"Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy","volume":"63","author":"Goodman","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB15","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2001.00949.x","article-title":"Improved assessment of bone turnover by the PTH-(1\u201384)\/large C-PTH fragments ratio in ESRD patients","volume":"60","author":"Monier-Faugere","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB16","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2003.00915.x","article-title":"Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis","volume":"63","author":"Salusky","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB17","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","article-title":"Circulating biochemical markers of bone remodeling in uremic patients","volume":"55","author":"Urena","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB19","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/ndt\/13.9.2294","article-title":"Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients","volume":"13","author":"Coen","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB20","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB21","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ndt\/15.7.945","article-title":"The role of cytokines in skeletal remodelling","volume":"15","author":"Gonzalez","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB22","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1359\/jbmr.1999.14.10.1680","article-title":"Growth retardation in children with chronic renal failure","volume":"14","author":"Kuizon","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB23","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1755.1998.00045.x","article-title":"Intermittent calcitriol therapy in secondary hyperparathyroidism","volume":"54","author":"Salusky","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1523-1755.1998.00724.x","article-title":"Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD","volume":"53","author":"Kuizon","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB25","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1046\/j.1523-1755.1999.07305.x","article-title":"New analogs of vitamin D3","volume":"73","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB26","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1523-1755.2002.kid573.x","article-title":"Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats","volume":"62","author":"Slatopolsky","year":"2002","journal-title":"Kidney Int"},{"issue":"suppl 5","key":"10.1053\/j.ajkd.2003.12.003_BIB27","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1053\/ajkd.2001.28110","article-title":"Suppression of parathyroid hormone secretion in hemodialysis patients","volume":"38","author":"Sprague","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB28","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-nor-1-a-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact PTH in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2003.12.003_BIB29","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1053\/ajkd.1998.v32.pm9808145","article-title":"Therapy of secondary hyperparathyroidism with 19-nor-1\u03b1,25- dihydroxyvitamin D2","volume":"32","author":"Martin","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB30","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/ajkd.2000.16193","article-title":"Intermittent doxercalciferol (1\u03b1-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism","volume":"36","author":"Frazao","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/ajkd.2001.22077","article-title":"Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1\u03b1-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism","volume":"37","author":"Maung","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"suppl 10","key":"10.1053\/j.ajkd.2003.12.003_BIB32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ndt\/17.suppl_10.28","article-title":"Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study","volume":"17","author":"Akizawa","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/ajkd.1998.v32.pm9708607","article-title":"Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism","volume":"32","author":"Akiba","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB34","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1053\/ajkd.2001.29283","article-title":"Strategies to minimize bone disease in renal failure","volume":"38","author":"Martin","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000046993","article-title":"Vitamin D analogs for the treatment of secondary hyperparathyroidism","volume":"20","author":"Slatopolsky","year":"2002","journal-title":"Blood Purif"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000057470","article-title":"Vitamin D analogs","volume":"25","author":"Brown","year":"1999","journal-title":"Miner Electrolyte Metab"},{"issue":"suppl 5","key":"10.1053\/j.ajkd.2003.12.003_BIB37","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1053\/ajkd.2001.28112","article-title":"Paricalcitol dosing according to body weight or severity of hyperparathyroidism","volume":"38","author":"Martin","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMe038104","article-title":"Paricalcitol as compared with calcitriol in patients undergoing hemodialysis","volume":"349","author":"Drueke","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB40","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/ndt\/14.12.2907","article-title":"Long-term effects of sevelamer hydrochloride on the calcium \u00d7 phosphate product and lipid profile of haemodialysis patients","volume":"14","author":"Chertow","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2003.12.003_BIB42","doi-asserted-by":"crossref","first-page":"S408","DOI":"10.1177\/089686089901902S66","article-title":"Calcitriol, lanthanum carbonate, and other new phosphate binders in the management of renal osteodystrophy","volume":"19","author":"Hutchison","year":"1999","journal-title":"Perit Dial Int"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00041552-200003000-00005","article-title":"Calcimimetic agents and the calcium-sensing receptor","volume":"9","author":"Coburn","year":"2000","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.med.52.1.203","article-title":"Prevention of uremic bone disease using calcimimetic compounds","volume":"52","author":"Olgaard","year":"2001","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB45","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","article-title":"The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease","volume":"14","author":"Quarles","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2003.12.003_BIB46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.semnephrol.2003.08.019","article-title":"Parathyroid hormone","volume":"24","author":"Martin","year":"2004","journal-title":"Semin Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638603015816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638603015816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:22:47Z","timestamp":1759454567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638603015816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0272638603015816"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2003.12.003","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2003.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}